B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity—A Meta-Analysis

B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity—A Meta-Analysis

Up to 15% of coronavirus disease 2019 (COVID-19) patients experience severe clinical presentation, resulting in acute respiratory distress (ARDS) and finally death. N-terminal natriuretic peptide (NT-proBNP) is associated with a worse prognosis in patients with ARDS. However, whether or not this pep...

Full description

Bibliographic Details
Main Authors: Sabato Sorrentino, Michele Cacia, Isabella Leo, Alberto Polimeni, Jolanda Sabatino, Carmen Anna Maria Spaccarotella, Annalisa Mongiardo, Salvatore De Rosa, Ciro Indolfi
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
NT-proBNP
death
COVID-19
SARS-CoV-2
Online Access:https://www.mdpi.com/2077-0383/9/9/2957

Internet

https://www.mdpi.com/2077-0383/9/9/2957

Similar Items